Hospital
Acadia-St. Landry Hospital Service District
Acadia-St. Landry Hospital Service District was paid $1.98M by Medicaid between Jan 2018 and Dec 2024, across 45 billing codes. Its largest line is 99283, emergency room visit (moderate) — 80% of everything it billed.
33Billing provider infoACADIA-ST. LANDRY HOSPITAL SERVICE DISTRICT
CHURCH POINT, LA 70525
CHURCH POINT, LA 70525
33aNPI1376540153assigned 07/07/2005
33bProvider typeCritical Access Hospital
28Total paid$1.98M
24GClaims77,677
24DCodes billed45
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Louisiana
Rank by total paid#22 of 40
Median peer was paid$3.19M
This provider vs. median0.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 13,403 | $105K | |
| 2019 | 11,797 | $105K | |
| 2020 | 10,175 | $104K | |
| 2021 | 15,786 | $380K | |
| 2022 | 9,837 | $480K | |
| 2023 | 9,595 | $470K | |
| 2024incomplete | 7,084 | $338K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 80% | 13,441 | 10,716 | $1.58M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 7.0% | 1,706 | 1,403 | $140K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.8% | 1,078 | 962 | $35K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.7% | 2,575 | 1,179 | $35K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1.7% | 894 | 382 | $34K |
| 80053 | Comprehensive metabolic panel | 1.4% | 3,764 | 3,308 | $28K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 3,483 | 3,064 | $19K |
| 36415 | Collection of venous blood by venipuncture | <1% | 6,129 | 5,086 | $13K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 692 | 625 | $10K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 428 | 381 | $9K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 660 | 618 | $9K |
| 84481 | <1% | 681 | 621 | $8K |
33 more codes
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 89 | $7K |
| 80061 | Lipid panel | <1% | 591 | $7K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 157 | $6K |
| 71045 | Radiologic examination, chest; single view | <1% | 110 | $5K |
| 84436 | <1% | 871 | $5K | |
| 87070 | <1% | 617 | $5K | |
| 84479 | <1% | 857 | $5K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 98 | $4K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 17 | $2K |
| 81003 | <1% | 1,434 | $2K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 128 | $2K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 31 | $2K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 90 | $1K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 148 | $1K |
| 84484 | <1% | 105 | $878.03 | |
| 82553 | <1% | 89 | $481.66 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 27 | $475.00 |
| 82550 | <1% | 112 | $374.54 | |
| 84439 | <1% | 59 | $333.74 | |
| 81025 | <1% | 29 | $230.13 | |
| 83880 | <1% | 17 | $196.30 | |
| 85027 | <1% | 15 | $74.20 | |
| 85007 | <1% | 15 | $34.10 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 24 | $33.00 |
| Q0244 | Injection, casirivimab and imdevimab, 1200 mg | <1% | 17 | $0.03 |
| 90791 | Psychiatric diagnostic evaluation | 0% | 50 | $0.00 |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 0% | 20,321 | $0.00 |
| G0177 | Training and educational services related to the care and treatment of patient's disabling mental health problems per session (45 minutes or more) | 0% | 5,039 | $0.00 |
| 90832 | Psychotherapy session, about 30 minutes | 0% | 161 | $0.00 |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | 0% | 32 | $0.00 |
| G0410 | Group psychotherapy other than of a multiple-family group, in a partial hospitalization or intensive outpatient setting, approximately 45 to 50 minutes | 0% | 10,757 | $0.00 |
| 90834 | Psychotherapy session, about 45 minutes | 0% | 14 | $0.00 |
| 05983 | 0% | 25 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLEJUNE, MICHAEL (CEO/ADMINISTRATOR)